United States · FDA National Drug Code directory
Clorazepate Dipotassium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51672-4042_56998160-f30b-670e-e063-6294a90ac8ff
- Product NDC
- 51672-4042
- Form
- TABLET
- Composition / generic term
- Clorazepate Dipotassium
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20000427
- Source listing expiry
- 20271231
Source-listed ingredients
- CLORAZEPATE DIPOTASSIUM — 3.75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (51672-4042-1) · 51672-4042-1
- 500 TABLET in 1 BOTTLE (51672-4042-2) · 51672-4042-2
- 1000 TABLET in 1 BOTTLE (51672-4042-3) · 51672-4042-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →